About the Authors

Oludamilola Akinmolayemi

Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Department of Internal Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America

Suzanne Saldanha

Roles Data curation, Writing – review & editing

Affiliation Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

Parag H. Joshi

Roles Writing – review & editing

Affiliation Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

Sneha Deodhar

Roles Writing – review & editing

Affiliation Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

Colby R. Ayers

Roles Formal analysis, Methodology

Affiliation Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

Ian J. Neeland

Roles Writing – review & editing

Affiliation University Hospitals Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America

Anand Rohatgi

Roles Conceptualization, Supervision, Validation, Writing – original draft, Writing – review & editing

anand.rohatgi@utsouthwestern.edu

Affiliation Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: AR is supported by NIH/NHLBI R01HL136724, NIH/NHLBI K24HL146838, and NHLBI R01HL146462. Disclosures include Merck research grant (significant), CSL Limited consultant (modest), HDL Diagnostics Advisory Board (modest). IJN has received honoraria, consulting, and speaker’s bureau fees, and travel support from Boehringer-Ingelheim/Lilly Alliance (significant), a research grant from Novo Nordisk (significant), and has been a member of a scientific advisory board regarding obesity for AMRA Medical (modest) and Merck (modest). PHJ has received grant support from Novo Nordisk (significant) and NASA (significant), advisory board fees from Bayer (modest) and Regeneron (modest), has equity interest in G3 Therapeutics, and has served as a site investigator (with all funds to the institution) for AstraZeneca, Sanofi, GlaxoSmithKline, and Novartis. All other authors declare no competing interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials.